Study finds biosimilars offer improved outcome and lower cost for rheumatoid arthritis treatment

A research team from the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) performed a cost-effectiveness analysis of treatment strategies for patients in Hong Kong with rheumatoid arthritis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup